January also revealed a growing disconnect between ASC operating performance and ASC real estate valuation. Commercial medical real estate data released mid-month showed cap rates for outpatient facilities rising into the 7.25–8.5% range, up from approximately 5.5–6% just a few years prior. Higher interest rates and tighter credit conditions continue to weigh heavily on valuations.

As a result, several high-performing ASCs discovered that despite stable or rising EBITDA, underlying real estate valuations declined by 10–20%. This shift complicates refinancing strategies, sale-leaseback transactions, and long-term physician liquidity planning. For many physician-owned centers, real estate represents 30–50% of total enterprise value, making this decoupling strategically significant.

January transactions confirmed that buyers increasingly underwrite land, shell, and tenant credit independently from clinical operations. Strong EBITDA alone no longer guarantees favorable real estate terms. Lease structure, remaining lease term, tenant credit quality, and replacement cost now play a larger role in valuation than historical operating margins.

Real estate has effectively become an independent risk variable. Operators who fail to manage it deliberately may find that clinical success does not automatically translate into total enterprise value growth.